Yun Wang

Selective Publications

  1. Liu, QR;Huang, NS;Qu, H;O’Connell, JF;Gonzalez-Mariscal, I;Santa-Cruz-Calvo, S;Doyle, ME;Xi, ZX;Wang, Y;Onaivi, ES;Egan, JM(2018) Identification of novel mouse and rat CB1R isoforms and in silico modeling of human CB1R for peripheral cannabinoid therapeutics. Acta Pharmacologica Sinica. Article in Press.
  2. Wu KJ, Yu SJ, Chiang CW, Lee YW, Yen BL, Tseng PC, Hsu CS, Kuo LW, Wang Y (2018) Neuroprotective action of human Wharton’s Jelly derived-mesenchymal stromal cell transplants in a rodent model of stroke. Cell Transplantation, In Press
  3. Chen S, Yu SJ, Li Y, Lecca D, Glotfelty E, Kim HK, Choi HI, Hoffer BJ, Greig NH, Kim DS, Wang Y (2018) Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease. Sci Rep 8:10722
  4. Anttila,J.E., Albert,K., Wires,E.S., Loram,L., Watkins,L., Rice,K., Wang,Y., Harvey,B.K., and Airavaara,M. (2018). Post-stroke intranasal (+)-naloxone delivery reduces microglial activation and improves behavioral recovery from ischemic injury. eNeuro 5, e0395-17.
  5. Chen,Y.H., Wu,K.L., Tsai,M.T., Chien,W.H., Chen,M.L., and Wang,Y. (2017). Methadone enhances human influenza A virus replication. Addict Biol 22, 257-271.
  6. Chen,Y.H., Wu,K.J., Wu,K.L., Wu,K.L., Tsai,H.M., Chen,M.L., Chen,Y.W., Hsieh,W., Lin,C.M., and Wang,Y. (2017). Recombinant adeno-associated virus-mediated expression of methamphetamine antibody attenuates methamphetamine-induced hyperactivity in mice. Sci Rep 7, 46301.
  7. Kim,D.S., Choi,H.I., Wang,Y., Luo,Y., Hoffer,B.J., and Greig,N.H. (2017). A new treatment strategy for Parkinson’s disease through the gut-brain axis: The Glucagon-like Peptide-1 receptor pathway. Cell Transplant. 26, 1560-1571.
  8. Li,Y., Wu,K.J., Yu,S.J., Tamargo,I.A., Wang,Y., and Greig,N.H. (2017). Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke. Exp. Neurol. 288, 104-113.
  9. Lin,J.H., Hsieh,Y.C., Chen,Y.C., Wang,Y., Chen,C.C., and Chiang,Y.H. (2017). Diagnostic accuracy of standardised qualitative sensory test in the detection of lumbar lateral stenosis involving the L5 nerve root. Sci Rep 7, 10598.
  10. Liu,T.H., Chung,R.H., Wang,S.C., Fang,C.P., Tsou,H.H., Shih,C.L., Kuo,H.W., Wang,Y., and Liu,Y.L. (2017). Missense mutation at CLDN8 associated with a high plasma interferon gamma-inducible protein 10 level in methadone-maintained patients with urine test positive for morphine. Plos one 12, e0187639.
  11. Tamargo,I.A., Bader,M., Li,Y., Yu,S.J., Wang,Y., Talbot,K., DiMarchi,R.D., Pick,C.G., and Greig,N.H. (2017). Novel GLP-1R/GIPR co-agonist “twincretin” is neuroprotective in cell and rodent models of mild traumatic brain injury. Exp. Neurol. 288, 176-186.
  12. Wu,K.J., Yu,S., Lee,J.Y., Hoffer,B., and Wang,Y. (2017). Improving neurorepair in stroke brain through endogenous neurogenesis-enhancing drugs. Cell Transplant. 26, 1596-1600.
  13. Wu,K.J., Yu,S.J., Shia,K.S., Wu,C.H., Song,J.S., Kuan,H.H., Yeh,K.C., Chen,C.T., Bae,E., and Wang,Y. (2017). A novel CXCR4 antagonist CX549 induces neuroprotection in stroke brain. Cell Transplant. 26, 571-583.
  14. Yu,S.J., Airavaara,M., Wu,K.J., Harvey,B.K., Liu,H.S., Yang,Y., Zacharek,A., Chen,J., and Wang,Y. (2017). 9-cis retinoic acid induces neurorepair in stroke brain. Sci Rep 7, 4512.
  15. Kuo,C.C., Shen,H., Harvey,B.K., Yu,S.J., Kopajtic,T., Hinkle,J.J., Kyrkanides,S., Katz,J.L., and Wang,Y. (2016). Differential modulation of methamphetamine-mediated behavioral sensitization by overexpression of Mu opioid receptors in nucleus accumbens and ventral tegmental area. Psychopharmacology (Berl) 233, 661-672.
  16. Liu,H.S., Shen,H., Luo,Y., Hoffer,B.J., Wang,Y., and Yang,Y. (2016). Post-treatment with cocaine- and amphetamine-regulated transcript enhances infarct resolution, reinnervation, and angiogenesis in stroke rats – an MRI study. NMR Biomed 29, 361-370.
  17. Peng,K.Y., Lee,Y.W., Hsu,P.J., Wang,H.H., Wang,Y., Liou,J.Y., Hsu,S.H., Wu,K.K., and Yen,B.L. (2016). Human pluripotent stem cell (PSC)-derived mesenchymal stem cells (MSCs) show potent neurogenic capacity which is enhanced with cytoskeletal rearrangement. Oncotarget 7, 43949-43959.
  18. Yu,S.J., Wu,K.J., Bae,E.K., Hsu,M.J., Richie,C.T., Harvey,B.K., and Wang,Y. (2016). Methamphetamine induces a rapid increase of intracellular Ca++ levels in neurons overexpressing GCaMP5. Addict Biol 21, 255-266.
  19. Cui,X., Chopp,M., Zacharek,A., Karasinska,J.M., Cui,Y., Ning,R., Zhang,Y., Wang,Y., and Chen,J. (2015). Deficiency of brain ATP-binding cassette transporter A-1 exacerbates blood-brain barrier and white matter damage after stroke. Stroke 46, 827-834.
  20. Wu,K.J., Yu,S.J., Chiang,C.W., Cho,K.H., Lee,Y.W., Yen,B.L., Kuo,L.W., and Wang,Y. (2015). Transplantation of human placenta-derived multipotent stem cells reduces ischemic brain injury in adult rats. Cell Transplant. 24, 459-470.
  21. Yu,S.J., Reiner,D., Shen,H., Wu,K.J., Liu,Q.R., and Wang,Y. (2015). Time-dependent protection of CB2 receptor agonist in stroke. Plos one 10, e0132487.
  22. Reiner,D.J., Yu,S.J., Shen,H., He,Y., Bae,E., and Wang,Y. (2014). 9-Cis retinoic acid protects against methamphetamine-induced neurotoxicity in nigrostriatal dopamine neurons. Neurotox. Res. 25, 248-261.

Last Update: 2018-10-30

Comments are closed.